• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可预防疾病模型:对比剂肾病与心脏手术相关急性肾损伤

Models of preventable disease: contrast-induced nephropathy and cardiac surgery-associated acute kidney injury.

作者信息

Shaw Andrew

机构信息

Department of Anesthesiology, Duke University Medical Center, Durham, N.C., USA.

出版信息

Contrib Nephrol. 2011;174:156-162. doi: 10.1159/000329387. Epub 2011 Sep 9.

DOI:10.1159/000329387
PMID:21921620
Abstract

In order to prevent a disease, its temporal nature (or at least when it starts) needs to be clearly defined. In acute kidney injury (AKI), this is usually not possible because the current diagnostic criteria are retrospective. Contrast-induced nephropathy (CIN) and cardiac surgery-associated acute kidney injury (CSA-AKI) are both thought of as potentially preventable acute renal lesions because the timing of the insult is known precisely. While this is true, knowledge of the exact biological processes that give rise to each condition is lacking, although there are several common themes - notably ischemia - that pervade the literature describing these diseases. Despite this, progress in prevention has been slow, and to date there are no therapies indicated for preventing either CIN or CSA-AKI. The best we can currently do is to recommend aggressive parenteral hydration, avoid compounds we know are nephrotoxic, and avoid unnecessary hypoxia and hypotension. While there is still clearly a long way to go before either of these acute kidney conditions can be described as preventable, the use of major adverse kidney events - death, dialysis and incident or progressive chronic kidney disease at 90 days - as a composite endpoint in clinical trials of putative prevention agents would represent a significant step forwards.

摘要

为了预防疾病,需要明确其时间特性(或至少明确其起始时间)。在急性肾损伤(AKI)中,这通常是不可能的,因为目前的诊断标准是回顾性的。造影剂肾病(CIN)和心脏手术相关急性肾损伤(CSA-AKI)都被认为是潜在可预防的急性肾损伤,因为损伤的时间是确切已知的。虽然确实如此,但对于引发每种病症的确切生物学过程仍缺乏了解,尽管在描述这些疾病的文献中有几个共同的主题——尤其是缺血。尽管如此,预防方面的进展一直缓慢,迄今为止,尚无用于预防CIN或CSA-AKI的疗法。我们目前所能做的最好的事情就是建议积极的肠外补液、避免使用已知具有肾毒性的化合物,以及避免不必要的缺氧和低血压。虽然在这两种急性肾病症被描述为可预防之前显然还有很长的路要走,但在推定预防药物的临床试验中,将主要不良肾脏事件——死亡、透析以及90天时新发或进展性慢性肾脏病——作为复合终点将是向前迈出的重要一步。

相似文献

1
Models of preventable disease: contrast-induced nephropathy and cardiac surgery-associated acute kidney injury.可预防疾病模型:对比剂肾病与心脏手术相关急性肾损伤
Contrib Nephrol. 2011;174:156-162. doi: 10.1159/000329387. Epub 2011 Sep 9.
2
Impact of cardiac catheterization timing and contrast media dose on acute kidney injury after cardiac surgery.心脏导管插入术时机和造影剂剂量对心脏手术后急性肾损伤的影响。
BMC Cardiovasc Disord. 2018 Oct 5;18(1):191. doi: 10.1186/s12872-018-0928-8.
3
Management of Cardiac Surgery-Associated Acute Kidney Injury.心脏手术相关急性肾损伤的管理
Contrib Nephrol. 2016;187:131-42. doi: 10.1159/000443011. Epub 2016 Feb 8.
4
Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.对比剂肾病与心脏手术后急性肾损伤和死亡风险。
Ann Thorac Surg. 2012 Sep;94(3):772-6. doi: 10.1016/j.athoracsur.2012.04.089. Epub 2012 Jul 25.
5
Current concepts of contrast-induced nephropathy: a brief review.当前对比剂诱导肾病的概念:简要综述。
J Chin Med Assoc. 2013 Dec;76(12):673-81. doi: 10.1016/j.jcma.2013.08.011. Epub 2013 Oct 3.
6
[Iodinated contrast agent-induced nephropathy].[碘化造影剂所致肾病]
Radiologe. 2007 Sep;47(9):761-7. doi: 10.1007/s00117-007-1549-x.
7
Trimetazidine in the prevention of contrast-induced nephropathy in chronic kidney disease.曲美他嗪预防慢性肾脏病患者对比剂肾病的研究
Cardiovasc Revasc Med. 2017 Jul-Aug;18(5):315-319. doi: 10.1016/j.carrev.2017.02.006. Epub 2017 Feb 10.
8
Acute kidney injury after percutaneous coronary intervention: Rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-study.经皮冠状动脉介入治疗后急性肾损伤:AKI-MATRIX(通过桡动脉穿刺部位及血管造影X系统全面应用减少急性肾损伤不良出血事件)子研究的原理
Catheter Cardiovasc Interv. 2015 Nov;86(5):950-7. doi: 10.1002/ccd.25932. Epub 2015 Apr 9.
9
Update on clinical trials for the prevention of acute kidney injury in patients undergoing cardiac surgery.心脏手术患者急性肾损伤预防的临床试验进展。
Am J Surg. 2013 Jul;206(1):86-95. doi: 10.1016/j.amjsurg.2012.08.007. Epub 2013 Feb 11.
10
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.速尿联合等渗盐水水化预防对比剂肾病:MYTHOS 研究(对比剂肾病预防中渗透性利尿联合等渗盐水水化与标准水化的比较)
JACC Cardiovasc Interv. 2012 Jan;5(1):90-7. doi: 10.1016/j.jcin.2011.08.017.

引用本文的文献

1
Major adverse kidney events as an endpoint in acute kidney injury trials: is it time for a RE-MAKE?将主要不良肾脏事件作为急性肾损伤试验的一个终点:是时候重新制定标准了吗?
Intensive Care Med. 2024 Oct;50(10):1723-1724. doi: 10.1007/s00134-024-07602-5. Epub 2024 Aug 15.
2
Recommendations for clinical trial design in acute kidney injury from the 31st acute disease quality initiative consensus conference. A consensus statement.急性肾损伤临床试验设计的建议来自第 31 届急性疾病质量倡议共识会议。一项共识声明。
Intensive Care Med. 2024 Sep;50(9):1426-1437. doi: 10.1007/s00134-024-07560-y. Epub 2024 Aug 8.
3
Heterogeneity in the definition of major adverse kidney events: a scoping review.
主要不良肾脏事件定义中的异质性:范围综述。
Intensive Care Med. 2024 Jul;50(7):1049-1063. doi: 10.1007/s00134-024-07480-x. Epub 2024 May 27.
4
Unraveling Chronic Cardiovascular and Kidney Disorder through the Butterfly Effect.通过蝴蝶效应揭示慢性心血管和肾脏疾病
Diagnostics (Basel). 2024 Feb 20;14(5):463. doi: 10.3390/diagnostics14050463.
5
Predictive Value of Hyperuricemia in Cardiac Patients with Post-Contrast Acute Kidney Injury (PC-AKI) and Different Basic Renal Functions: A Meta-Analysis.高尿酸血症对造影剂后急性肾损伤(PC-AKI)及不同基础肾功能的心脏病患者的预测价值:一项荟萃分析。
Iran J Public Health. 2022 Dec;51(12):2641-2653. doi: 10.18502/ijph.v51i12.11455.
6
Predictive value of two different definitions of contrast-associated acute kidney injury for long-term major adverse kidney events in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.在接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者中,两种不同定义的对比剂相关急性肾损伤对长期主要不良肾脏事件的预测价值。
Cardiol J. 2024;31(1):53-61. doi: 10.5603/CJ.a2022.0034. Epub 2022 May 17.
7
Post-contrast acute kidney injury in a hospitalized population: short-, mid-, and long-term outcome and risk factors for adverse events.住院患者造影剂后急性肾损伤:短期、中期和长期结局及不良事件的危险因素。
Eur Radiol. 2020 Jun;30(6):3516-3527. doi: 10.1007/s00330-020-06690-3. Epub 2020 Feb 21.
8
Evaluation of five different renal recovery definitions for estimation of long-term outcomes of cardiac surgery associated acute kidney injury.评估五种不同的肾脏恢复定义,以估计心脏手术相关急性肾损伤的长期结局。
BMC Nephrol. 2019 Nov 21;20(1):427. doi: 10.1186/s12882-019-1613-6.
9
Contrast induced acute kidney injury and the role of beta-blockers in its prevention.对比剂诱导的急性肾损伤及β受体阻滞剂在其预防中的作用。
J Thorac Dis. 2019 Jul;11(7):2689-2694. doi: 10.21037/jtd.2019.06.53.
10
Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial.脓毒症患者中平衡晶体液与生理盐水的比较: SMART 临床试验的二次分析。
Am J Respir Crit Care Med. 2019 Dec 15;200(12):1487-1495. doi: 10.1164/rccm.201903-0557OC.